Treatment of acute heart failure using levosimendan for a patient with dilated cardiomyopathy, chronic renal failure, and hypertension

Pediatric Cardiology

Volumn 32, Issue 7, 2011, Pages 1012-1016

  Lobo Martínez, Pablo ^a   Oulego Erroz, Ignacio ^a   Gautreux Minaya, Sandra ^a   Rodríguez Fernández, Luis Miguel ^a  

^a Gerencia Regional de Salud de Castilla y León   (Spain)

Author keywords

Acute heart failure; Glycogenosis type Ia; Levosimendan

Indexed keywords

BICARBONATE; ERYTHROPOIETIN; FUROSEMIDE; LAMOTRIGINE; LEVOSIMENDAN; MILRINONE; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

ABSENCE OF SIDE EFFECTS; ACUTE HEART FAILURE; ADOLESCENT; ARTICLE; CARDIOMEGALY; CASE REPORT; CHRONIC KIDNEY FAILURE; CONGESTIVE CARDIOMYOPATHY; DIURETIC THERAPY; ECHOCARDIOGRAPH; GLYCOGEN STORAGE DISEASE TYPE 1; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE FUNCTION; HEMODYNAMICS; HEPATOSPLENOMEGALY; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INOTROPISM; LUNG EDEMA; MITRAL VALVE REGURGITATION; NEUROLOGIC DISEASE; OXYGEN SATURATION; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS; TRICUSPID VALVE REGURGITATION; ACUTE DISEASE; DIURESIS; DOPPLER ECHOCARDIOGRAPHY; DOSE RESPONSE; DRUG EFFECT; FOLLOW UP; HEART CONTRACTION; HEART FAILURE; HEART STROKE VOLUME; INTRAVENOUS DRUG ADMINISTRATION; MALE; PATHOPHYSIOLOGY;

ACUTE DISEASE; ADOLESCENT; CARDIOMYOPATHY, DILATED; CARDIOTONIC AGENTS; DIURESIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FOLLOW-UP STUDIES; GLYCOGEN STORAGE DISEASE TYPE I; HEART FAILURE; HUMANS; HYDRAZONES; HYPERTENSION; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; MALE; MYOCARDIAL CONTRACTION; PYRIDAZINES; STROKE VOLUME;

EID: 84859633824     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-011-0041-6     Document Type: Article

References (12)

1. Avgeropoulou C, Andreadou I, Markantosis S (2005) The calcium sensitizer levosimendan improves oxidative damage, BNP and preinflamatory cytokine levels in patients with advanced descompensated heart failure in comparison to dobutamine. Eur J Heart Fail 7:882-887
2. De Luca L, Colucci WS, Nieminen MS, Massie BM, Gheorghiade M (2006) Evidence-based use of levosimendan in different clinical settings. Eur Heart J 27:1908-1920
3. Di Chiara L, Ricci Z, Garisto C, Morelli S, Giorni C, Vitale V, Di Donato RM, Picardo S (2010) Initial experience with levosimendan infusion for preoperative management of hypoplastic left heart syndrome. Pediatr Cardiol 31:166-167
4. Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Hariola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360:196-202
5. Givertz MM, Andreou C, Conrad CH, Colucci WS (2007) Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships. Circulation 115:1218-1224
6. Kivikko M, Lehtonen L, Colucci WS (2003) Sustained hemodynamic effects of intravenous levosimendan. Circulation 107:81-86
7. Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, Thakkar R, Padley RJ, Poder P, Kivikko M (2007) Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 297:1883-1891
8. Nieminen MS, Akkila J, Hasenfuss G, Kleber FX, Lehtonen LA, Mitrovic V, Nyquist O, Remme WJ (2000) Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. J Am Coll Cardiol 36:1903-1912
9. Packer M (1993) The search for the ideal positive inotropico agent. N Engl J Med 323:201-202
10. Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, Leier CV, LeJemtel TH, Loh E, Nicklas J, Ogilby D, Singh BN, Smith W (2000) Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Circulation 102:2222-2227
11. Ukkonen H, Saraste M, Akkila J, Knuuti J, Karanko M, Iida H, Lehikoinen P, Någren K, Lehtonen L, Voipio-Pulkki LM (2000) Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin Pharmacol Ther 68:522-531
12. + channel in rat ventricular cells. J Pharmacol Exp Ther 283:375-383